Login
  • Login
  • Cart
  • Contact Us
American Nephrology Nurses Association Logo

ILLUMINATE-C, a Single-arm, Phase 3 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 and CKD3b-5, Including Those on Hemodialysis

ILLUMINATE-C, a Single-arm, Phase 3 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 and CKD3b-5, Including Those on Hemodialysis

May 23, 2022
Collection: 2022 Posters
Credits: None available.
Type: Session
Speakers:
  • Philip Arnold, MSN, RN
Tags: lumasiran oxalate Primary hyperoxaluria type 1 PH1lumasiran plasma oxalate cl impaired kidney function plasma clinical trial
© 2022 Digitell, Inc. All Rights Reserved
Privacy Center
Shopping Cart
Item Price Remove